Product Description
Since last manyyears SaintroyLifescienceis leading manufacture, export and supplierofEpirubicin Hydrochloride for injectionfrom Surat, Gujarat, India. Epirubicin Hydrochloride for injection used in combination with other medications to treat breast cancer in patients who have had surgery to remove the tumor.
Tags: Epirubicin Hydrochloride for injection manufacturer, Epirubicin Hydrochloridefor injection exporter, Epirubicin Hydrochloride for injection supplier,and Epirubicin Hydrochloride for injection, whogmp approved Epirubicin Hydrochloridefor injection manufacturer and supplier, Epirubicin Hydrochloride Forinjection distributor, Epirubicin Hydrochloride for injection shipper, Epirubicin Hydrochloridefor injection 10 mg Epirubicin Hydrochloride for injection 10 mgsupplier,Epirubicin Hydrochloride for injection 10 mg.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility inGujarat, India.
Registration: Saintroy Lifescienceis interested inregistration of own brand or customer brands in ministryof health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country:Saintroy Lifescience Epirubicin Hydrochloridefor injection export to USA, Canada, Germany, Europe, France,Ghana, Nigeria, Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon,Peru, Chile, Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore,Malaysia, Hong Kong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau,Congo, Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua,Salvador, Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine,Algeria, Guyana, Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan,Kazakhstan.
Powerful Chemotherapeutic AgentEpirubicin Hydrochloride is indicated for various solid tumors, including breast and ovarian cancer. With its proven efficacy, it plays a crucial role in oncology, helping patients combat life-threatening malignancies under medical supervision.
Safe and Reliable AdministrationSupplied as a lyophilized red-orange powder in sealed glass vials, the product ensures stability and sterility until use. It must be reconstituted and administered intravenously by professionals trained in chemotherapy protocols to maximize safety and effectiveness.
Flexible Dosage StrengthsAvailable in 10 mg, 50 mg, and 100 mg vials, Epirubicin Hydrochloride allows healthcare providers to tailor chemotherapy doses to individual patient needs, improving therapeutic outcomes while minimizing potential adverse effects.
FAQ's of Epirubicin Hydrochloride for injection:
Q: How should Epirubicin Hydrochloride for Injection be reconstituted for administration?
A: Epirubicin Hydrochloride must be reconstituted according to the instructions in the prescribing information using sterile water for injection. Only trained healthcare professionals should handle this process to ensure proper dosing and safety.
Q: What are the available strengths of Epirubicin Hydrochloride for Injection?
A: The product is available in three strengths per single-use vial: 10 mg, 50 mg, and 100 mg, offering flexibility for different chemotherapy regimens as prescribed by oncologists.
Q: When is Epirubicin Hydrochloride used in cancer treatment?
A: Epirubicin Hydrochloride is typically used in protocols for breast cancer, ovarian cancer, and various other solid tumors, often as a part of combination chemotherapy regimens.
Q: Where should Epirubicin Hydrochloride for Injection be stored to maintain stability?
A: The vials should be stored in a cool, dry place to ensure the medication maintains its stability and efficacy throughout its shelf life of two years.
Q: What precautions must be taken during the administration of Epirubicin Hydrochloride?
A: Administration should be carried out by healthcare professionals trained in chemotherapy, as the drug requires precise dosing and careful patient monitoring to avoid complications.
Q: Who should avoid receiving Epirubicin Hydrochloride for Injection?
A: Patients with severe myelosuppression, a recent myocardial infarction, or hypersensitivity to Epirubicin or anthracyclines should not receive this medication, as it may pose serious health risks.
Q: What are the benefits of using Epirubicin Hydrochloride in oncology treatment?
A: Epirubicin Hydrochloride is valued for its effectiveness in shrinking tumors and improving patient outcomes in certain cancers when administered as prescribed by an oncologist.